Prognosis of Tyrosine Kinase Inhibitor Therapy for Non-Small Cell Lung Cancer

Prognosis of Tyrosine Kinase Inhibitor Therapy for Non-Small Cell Lung Cancer

Introduction: Non-small cell lung cancer (NSCLC) was the primary cause of death in lung cancer. Tyrosine kinase inhibitors (TKIs) were one of the management options for NSCLC. Meanwhile, serum carcinoembryonic antigen (CEA) plays a crucial role in the diagnosis and prognosis of NSCLC patients. This...

Full description

Saved in:
Bibliographic Details
Main Authors: Agus Andreas Santoso, Suryanti Dwi Pratiwi, Yani Jane Sugiri, Harun Al Rasyid, Aditya Sri Listyoko
Format: Article
Language:English
Published: Universitas Airlangga 2025-05-01
Series:Jurnal Respirasi
Subjects:
carcinoembryonic antigen (cea)
egfr-tki
nsclc
overall survival (os)
progression-free survival (pfs)
Online Access:https://e-journal.unair.ac.id/JR/article/view/68755
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items